Moderna's Covid-19 vaccine induced the desired immune responses in children ages 6 to 11 in a clinical trial and was found to be safe, the company said
Moderna Inc.’s Covid-19 vaccine was generally safe and induced the desired immune responses in children ages 6 to 11 in a clinical trial, according to the company.
The Cambridge, Mass., company said Monday that it would submit the results to health regulators in the U.S., Europe and elsewhere in seeking authorization to widen the use of its shots to include this younger age group.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Read more »
Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said.
Read more »
Fresh lockdowns in China as local Covid-19 infections spread to 11 provincesAuthorities in northern China are reimposing lockdowns and other emergency measures to curb the spread of coronavirus, with health officials warning of a worsening outbreak after the country recorded more than 100 cases across 11 provinces over the last week.
Read more »
Moderna says its Covid vaccine has strong results in children ages 6 to 11Data from an interim study showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
Read more »
Moderna says its low-dose COVID shot works for kids 6 to 11Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children. Competitor Pfizer's kid-sized vaccine doses are closer to widespread use, undergoing evaluation by the Food and Drug Administration for nearly the same age group — starting at age 5.
Read more »
Pfizer Says Its COVID Vaccine Is More Than 90% Effective In Kids Ages 5-11Pfizer Says Its COVID Vaccine Is More Than 90% Effective In Kids Ages 5-11 “Data submitted by Pfizer shows that a reduced dose of its COVID vaccine is extremely protective for kids ages 5 to 11.”
Read more »